Norepine (Noradrenaline Tartrate)

Norepinephrine tartrate, the active ingredient in Norepine, is an alpha‑adrenergic agonist presented as an injection for intravenous use. It is employed to increase vascular tone and cardiac output in patients experiencing hypotension, septic shock, or cardiogenic shock, often in intensive care settings to rapidly restore blood pressure.

GNH USA supplies Norepine as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, intensive care units and emergency departments worldwide. The product meets European Union quality standards and is manufactured under strict GMP conditions.

Norepine is used as a vasopressor to manage acute circulatory failure in several critical conditions.

- Hypotension: raises systemic blood pressure to maintain organ perfusion. - Septic shock: counteracts vasodilatory hypotension to improve hemodynamics. - Cardiogenic shock: supports cardiac output by increasing vascular resistance and contractility.

Intravenous norepinephrine may be associated with a range of adverse reactions, varying from frequent to rare.

Common Side Effects: - Headache - Tachycardia - Palpitations - Anxiety

Serious or Rare Side Effects: - Severe hypertension - Cardiac arrhythmias - Peripheral ischemia

When using Norepine, clinicians should observe several safety considerations to minimize risk.

- Monitor blood pressure: adjust infusion to avoid excessive hypertension. - Observe cardiac rhythm: watch for arrhythmias, especially in patients with pre‑existing heart disease. - Assess peripheral perfusion: discontinue if signs of ischemia develop. - Use caution in patients with pheochromocytoma: risk of hypertensive crisis. - Avoid abrupt discontinuation: taper infusion to prevent rebound hypotension. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Norepine can interact with other agents that influence cardiovascular tone or catecholamine metabolism.

Major Interactions (Avoid): - MAO inhibitors: risk of hypertensive crisis. - Tricyclic antidepressants: additive pressor effects. - β‑blockers: may blunt β‑adrenergic response, requiring higher norepinephrine doses.

Moderate Interactions (Monitor Closely): - Vasodilators (nitroglycerin, nitroprusside): may counteract pressor effect. - Calcium channel blockers: can enhance hypotensive risk. - Diuretics: may exacerbate volume depletion and affect response.